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I. Introduction and Objectives 
The work carried out is a part of the research line being conducted by the Nanoporous Films 
and Particles Group (NFP), of the Institute of Nanoscience of Aragon (INA) in the University of 
Zaragoza, regarding mesoporous materials synthesis and applications. This project comprises 
the preparation and characterization of rigid bimodal mesoporous silica monoliths, in order to 
investigate their potential applications as controlled drug release matrices. All work was based 
on the hexagonally-ordered mesoporous SBA-15 materials. Drug release experiments include 
release of the antibiotic cefuroxime from as-synthesized and amino-functionalized SBA-15 
powders and monoliths.  
Previous work carried out by the NFP group in controlled drug release has proven that drug 
loading and release kinetics vary in modified and unmodified mesoporous silica SBA-15 
powders, resulting in higher loadings and controlled release from functionalized materials 
(Carmona and Balas, unpublished data). Our monolithic structures have a bimodal pore 
structure, this is, the characteristic mesopores of SBA-15 and an array of interstitial 
macropores that may also function as drug reservoirs and affect diffusion of the drug. 
Moreover, the rigid monolithic structure has potential in functioning as an implantable drug 
delivery vehicle to be applied in traumatology and orthopedic surgery. One of the objectives of 
this work is to compare drug loading and release profiles of amino-modified and unmodified 
SBA-15 powders and the newly-prepared monoliths alike, in order to establish advantages and 
disadvantages and further investigate potential drug-delivery applications. 
The overall aim of this project is to present the synthesis and characterization of rigid SBA-15 
monoliths and to introduce the study of potential applications in controlled drug delivery. A 
theoretical background including key definitions and previous and current relative work is 
presented; the experimental protocols employed for preparation and testing of the materials 
under study are detailed, and final results are discussed. 
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II. Theoretical Background 
In this chapter, an overview of mesoporous materials, with an emphasis on mesoporous silica, 
is presented. Synthesis methods are reviewed, as well as some background regarding potential 
applications of mesoporous silica monolithic structures in the field of drug delivery. 
II.1. MESOPOROUS MATERIALS: MESOPOROUS SILICAS 
II.1.1. General considerations on porous solids 
Most solid materials, natural or synthetic, are porous to some extent. A porous solid can be 
defined as that which contains cavities, channels or interstices which are deeper than they are 
wide. These cavities, or pores, can be classified according to their availability to an external 
fluid or their shape1, as follows: 
Table II.1. Pore classification. 
 Type of pore Description 
Availability to an 
external fluid 
Closed pores Completely isolated pores (Fig. II.1, a) 
Open pores Continuous channel of communication with external surface 
(Fig. II.1, b, c, d, e, f) 
Blind pores Open on one end (Fig. II.1, b, f) 
Through pores Open on two ends (Fig. II.1, e) 
Shape Cylindrical Either open (Fig. II.1, c) or blind (Fig. II.1, f) 
Ink-bottle (Fig. II.1, b) 
Funnel-shaped (Fig. II.1, d) 
Slit-shaped (Fig. II.1, c) 
 
 
Fig. II.1. Schematic cross-section of a porous solid
1
. 
Some porous materials are defined as consolidated, which means that they exists as a 
relatively rigid macroscopic body whose dimensions exceed those of the pores by many orders 
of magnitude; they may be called agglomerates, or in the particular case in study, monoliths 
(from the Greek mono, single and lithos, stone). Others can be defined as unconsolidated, 
being non-rigid, loosely packed assemblages of individual particles; they may be called 
aggregates.  
a 
b 
c 
d e 
f 
c 
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These materials can be formed naturally or synthetically by several different routes. Pores can 
be an inherent characteristic of crystalline materials, with the pore size general being limited 
to molecular dimensions within a highly regular network. On the other hand, pores can be a 
result of constitutive processes in which aggregation and subsequent agglomeration of loose 
particles results in materials whose final structure depends on the original arrangement of the 
primary particles and their size. A third route is described as subtractive, in which certain 
elements of the original structure are selectively removed to create pores1. The latter is the 
route employed in the present study. 
It is necessary to define basic terms that correspond to characteristics of porous solids that 
were studied in the present investigation. These include: 
⋅ Pore size: distance between opposite walls of the pore (for example, diameter of 
cylindrical pores). This property is of major importance in practical applications of 
porous materials, as pore size directly affects selectivity and dictates the diffusion 
process through the material. 
⋅ Pore volume: volume of pores as measured by any given method. 
⋅ Specific surface area: accessible or detectable area of solid per unit mass of material. 
⋅ Porosity: ratio of total pore volume to the apparent volume of the particle or powder 
(excluding interstitial voids, unless otherwise specified). 
According to the IUPAC notation, mesoporous materials can be defined those with a pore 
diameter between 2 and 50 nm, between the pore sizes that define micro and macroporous 
materials. They have characteristic high surface areas, which make them particularly useful for 
a wide number of applications. 
II.1.2. Mesoporous materials 
Mesoporous materials synthesis was initially focused on silica-based materials. The first 
mesoporous materials synthesized were described in a patent from 1971 and resulted in the 
preparation of a low-density, surfactant-templated silica-based solid2,3. This invention, 
however, was practically ignored in the sense of a mesoporous material and it was not until 
the early 1990s when researchers in Japan4 synthesized and characterized a novel mesoporous 
silica solid, resulting in the formation of three-dimensional SiO2 networks with tunable pore 
sizes ranging from 2 to 4 nm. In the mid-1990s, Mobil Corporation Laboratories produced 
similar materials with a well-defined ordered pore structure, under the name Mobile 
Composition of Matter, or MCM5, intended to be used as molecular sieves, given that pore size 
control was achieved resulting in potentially more selective materials.  
In the past fifteen years, mesoporous materials research has focused mainly on synthesis and 
structures; methods of synthesis covered in the most cited papers from this time period 
include block copolymer templating6 and triblock copolymer synthesis7, among others. 
Structures of particular interest include mesoporous materials with hybrid organic/inorganic 
frameworks8 and crystalline or semi-crystalline frameworks9. Applications of said mesoporous 
materials mainly cover the areas where molecular recognition is necessary or useful, 
controlled drug delivery10, sensing11, and molecular sieving12, amongst others.  
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Preparation of non-oxide materials with mesoporous structures has played an especially 
important role in the 21st century, beginning with the invention of mesoporous carbon 
materials13. New families of mesoporous materials have been created due to these trends in 
research. Non-siliceous ordered mesoporous materials are by now accessible in a wide range 
of compositions14. 
Ordered mesoporous silicas, however, are still an important and ongoing field of research, and 
new biomedical applications focus mainly on drug release, including research on release via 
mesoporous silica coating of magnetic nanoparticles,  smart (stimuli-responsive) drug delivery 
systems, etc. Other applications of mesoporous silica currently under study include templating 
to obtain metal nanowires, nanoreactor technology and as supports for noble metal 
nanoparticle catalysts. 
II.1.3. Ordered mesoporous silica: SBA-15 synthesis 
Well-known nanoporous siliceous materials are zeolites, which provide excellent catalytic 
properties by virtue of their crystalline nanostructured aluminosilicate network. However, 
their applications are limited by the relatively small pore openings (<1nm); therefore, pore 
enlargement was one of the main aspects in zeolite chemistry. Larger pores are present in 
porous glasses and porous gels which were known as mesoporous materials at the time of the 
discovery of MCM-41. However, they showed disordered pore systems with broad pore size 
distributions. 
With MCM-41, the first mesoporous solid with a regularly ordered pore arrangement and a 
very narrow pore size distribution was achieved. The original MCM-41 synthesis was carried 
out in water under alkaline conditions. In the same way as zeolite synthesis, organic molecules 
(surfactants) function as templates forming an ordered organic–inorganic composite material. 
In the broadest sense a template may be defined as a central structure about which a network 
forms in such a way that removal of the template creates a cavity with morphological features 
related to those of the template15. Via calcination or extraction the surfactant is removed, 
leaving the porous siliceous network. However, in contrast to zeolites, the templates are not 
single organic molecules but liquid-crystalline self-assembled surfactant molecules (see Fig. 
II.2). The formation of the inorganic-organic composites is based on electrostatic interactions 
between the positively charged surfactants and the negatively charged siliceous species.  
 
Fig. II.2. General concept for synthesis of mesoporous silica from micelle template
16
. 
The liquid-crystal-controlled synthesis of MCM-41 opened a wide variety of synthesis 
approaches for developing new materials. The successful preparation of new porous materials 
Silica source 
Micelle from 
surfactant, triblock-
copolymer, etc. 
Silica formation 
Template removal 
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could be achieved by developing new synthesis pathways and by taking advantage of the 
liquid-crystal chemistry provided by the surfactant. 
The original approach was extended to the use of triblock copolymer templates under acidic 
conditions, by which means the Santa Barbara Amorphous (SBA) silica phases were 
synthesized7. The material under study, SBA-15, is characterized by a large BET surface area 
(>700m2/g) with large pore diameter (~ 8nm) and large pore wall thickness. The large wall 
thickness results in higher hydrothermal stability than M41S materials17. Furthermore, SBA-15 
exhibits continuous porous channels and has a characteristic hexagonal structure (p6mm)18. 
In the case of SBA-15 synthesis, a nonionic triblock copolymer, namely  Pluronic (P123)19 is 
used as a micelle template. P123 is one of the Pluronics triblock copolymers, which are 
composed of a central hydrophobic chain of polyoxypropylene flanked by two hydrophilic 
chains of polyoxyethylene (see Fig. II.3); its nominal chemical formula is 
HO(CH2CH2O)20(CH2CH(CH3)O)70(CH2CH2O)20H, which corresponds to a molecular weight of 
about 5800 Da.  
 
Fig. II.3. Molecular structure of Pluronics® triblock copolymers. 
Because of their amphiphilic structure, these triblock copolymers have surfactant properties 
that make them useful in many applications. As a result of their amphiphilic nature, surfactants 
can associate into supramolecular arrays, forming micelles with a configuration that depends 
on the nature of the solvent (an aqueous solvent, for example, would lead to micelles with 
hydrophobic centers and hydrophilic tails). The extent of micellization, the shape of the 
micelles, and the aggregation of micelles into liquid crystals depend on the surfactant 
concentration. At slightly higher concentrations, called the critical micelle concentration 
(CMC1), the individual surfactant molecules form small, spherical aggregates (micelles). At 
higher concentrations (CMC2), where the amount of solvent available between the micelles 
decreases, spherical micelles can coalesce to form elongated cylindrical micelles (characteristic 
templates for SBA-15). At slightly higher concentrations, liquid-crystalline (LC) phases form;  as 
concentration increases, rodlike micelles aggregate to form hexagonal close-packed LC arrays 
and cubic bicontinuous LC phases form followed by LC lamellar phases20.  
The silica source employed for SBA-15 synthesis is the metal alkoxide tetraethyl orthosilicate 
(TEOS), which is a tetrahedral molecule consisting of four ethyl groups attached to a SiO4
4- ion, 
called an orthosilicate (see Fig. II.4). The nominal chemical formula of TEOS is Si(OC2H5)4.  
 
Fig. II.4. Molecular structure of tetraethylorthosilicate (TEOS). 
The synthesis of mesoporous silica follows a metal alkoxide-based sol-gel reaction. The sol-gel 
transition of a metal alkoxide solution is generally caused by two kinds of reactions, i.e., 
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hydrolysis and polycondensation. Although the former one is necessary for the latter to take 
place, these reactions are known to proceed in parallel from a very early stage of the whole 
reaction21. In usual cases, the hydrolysis is initiated by mixing water with alkoxide in the 
presence of alcohol as a co-solvent (Ec. II.1). The hydrolysis of M-OR produces M-OH which 
subsequently condenses with other M-OH to produce a polycondensed species containing an 
M-O-M linkage and water (Ec. II.2). A successive condensation leads to the growth of 
metaloxane oligomers which subsequently link together to form a gel network (Ec. II.3). In the 
presence of a limited amount of water, the alcohol producing condensation is also possible. 
The overall reactions for silicon alkoxide, Si(OR)4 are expressed as follows: 
 + 	
 → 	 + 	 …(Ec. II.1) 
 − 	 +  − 	 →  −  −  + 	
 …(Ec. II.2) 
 − 	 +  −  →  −  −  + 	 …(Ec. II.3) 
TEOS has the remarkable property of easily converting into silicon dioxide; a silica network 
with silanol groups on the external surface is obtained and the side product is ethanol. Silicon 
alkoxides exhibit extraordinarily slow hydrolysis and polycondensation kinetics compared to 
other metal alkoxides. For this reason, a controlled hydrolysis of silicon alkoxides is much 
easier and the silica gel materials can be processed into various morphologies by varying the 
processing method. The reaction proceeds as was described above, in summary: 

	 + 2	
 → 
 + 4
	 …(Ec. II.4) 
For the case of SBA-15 synthesis, TEOS molecules are condensed on the hydrophilic surface of 
cylindrical micelles, ensuring that a faithful replica of the template is obtained. A fundamental 
condition for these methods of synthesis is that an attractive interaction between the 
template and the silica precursor is produced to ensure inclusion of the structure director 
without phase separation taking place. Interactions between nonionic templates (as P123) and 
silica sources are mediated through hydrogen bonds22. The structure of the wall of the 
resulting pores consists of a disordered net- work of siloxane bridges and free silanol groups ; 
this framework is well suited for the development of bonded selective sorption phases, via 
functionalization with organic molecules (see section III.1). 
II.2. BIMODAL MESOPOROUS SILICA MONOLITHS 
Mesoporous silicas were initially synthesized exclusively as powders, which made them 
suitable for catalytic and separation applications, with a variety of ordered mesophase 
architectures available (cubic, hexagonal, lamellar, etc), as was mentioned previously. Since 
then, however, efforts to improve the processability and broaden application possibilities of 
these materials have been made, resulting in low-molecular weight surfactant/inorganic 
mesophase composites and mesoporous solids in the form of films, spheres, etc.  
Optically transparent silica/block copolymer monoliths have been synthesized with high 
degrees of mesoscopic order, by means of solvent evaporation within the mesostructure (note 
that the natural meaning of monolith is a geological feature such as a mountain, consisting of a 
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single massive stone or rock)23,24. These monoliths, although rigid and free of cracks, are not 
mesoporous materials, but mesostructured composites as the block copolymer template is not 
removed after synthesis25.  
Monolithic silicas with well-defined porous structures have been mainly focused on 
investigations for applications in separations. HPLC columns based on such materials were first 
reported in 199626, and are characterized by higher total porosity and permeability compared 
to packed columns, allowing operation at low pressures, yet at higher flow rates, thus reducing 
the analysis time drastically. Monolithic silica HPLC columns are already marketed by Merck 
Co. under the trade name Chromolith™. These monoliths are readily prepared inside HPLC 
columns, for exclusive use in chromatography. 
For many applications, such as size selective adsorption27 materials with both small and large 
pores arranged in a hierarchical structure-in-structure fashion are desirable. So-called bimodal 
silica monoliths were first synthesized by Nakanishi, et. al. in 2005 by direct synthesis28, 
resulting in confined monoliths with an ordered hierarchical porous structure.  
A common problem regarding preparation said structures, however, is that they tend to be 
mechanically unstable unless encapsulated or embedded in a polymeric network (i.e., 
monoliths tend to crack upon calcination and removing from the mold, yielding irregular 
pieces and coarse powders, especially as the diameter of the monolith decreases). Leventis, et. 
al., prepared polymer-encapsulated bimodal monoliths with increased mechanic stability. The 
same study includes attempts to prepare monoliths without polymeric encapsulation, proving 
unsuccessful29.  
In response to this and due to the important amount of potential applications, various 
techniques for synthesizing silica monoliths with an ordered macro/mesoporous structure 
were developed. Bimodal macro/mesoporous silica monoliths can be prepared in two ways: by 
direct-templating of mesoporous silica in a mold that holds the desired shape of the monolith 
(dual-templating techniques30), and by using as-synthesized or modified mesoporous silica 
within a polymeric network that aids in holding the desired shape31. Another preparation 
method is by controlled fusion of mesoporous spherical silica particles32, yielding mechanically 
stable monoliths with tunable open macropores and surfactant-templated ordered 
mesopores. 
Recent advances in research concerning hierarchically ordered mesoporous silica monoliths 
are focused mainly on applications in catalysis and as catalytic reactors. These monolith rods 
were used as continuous flow catalytic microreactors after introduction of the active sites via 
grafting of organic functions, or via the transformation of the amorphous silica skeleton into 
other mesoporous silica species. These monolithic reactors demonstrated higher productivities 
than batch or packed-bed reactors for various model reactions33.  
II.3. CONTROLLED DRUG DELIVERY 
In the present study, silica monoliths exhibiting macropores of approximately 3 µm and 
mesopores ranging from 5 to 7 nm were prepared for testing in controlled drug delivery of an 
antibiotic as a model drug. 
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Drug delivery is a key factor contributing to the therapeutic and commercial potential of many 
drugs and related products. It is the driving force behind the development of many new 
devices and formulation-based projects.  
Conventional forms of drug delivery include oral, topical, inhaled, injections, etc. However, 
more sophisticated delivery systems must take into account pharmacokinetic principles, 
specific drug characteristics and variability of response - from one person to another and 
within the same person under different conditions. The therapeutic efficiency of a drug can be 
enhanced and toxic effects reduced if, for example, the amount and persistence of the drug in 
the vicinity of the target cells is increased, while reducing exposure of the drug to non-targeted 
cells. 
Design of any drug delivery system (DDS) must simultaneously take into consideration factors 
such as34: 
⋅ drug properties 
⋅ biocompatibility 
⋅ targeting abilities 
⋅ nature of delivery vehicle 
⋅ mechanism of drug release 
⋅ duration of delivery 
⋅ route of administration 
These are the principles behind controlled drug delivery. It is not easy, however, to achieve all 
these factors in one system because of their extensive independency. Various approaches for 
controlled drug delivery are briefly described below34: 
a) Localized drug delivery: It is desired in many cases to deliver drugs at a specific site 
inside the body, to a particular diseased tissue or organ, especially for drugs that tend 
to provoke unintended side effects that can be severe (i.e. anticancer drugs, anti-
inflammatory steroids, etc.). 
b) Targeted drug delivery: Delivery would typically involve a recognition event between 
the drug carrier and specific receptors at the cell or tissue surface. The concept of 
targeted drug delivery differs from localized delivery in the sense that the latter simply 
implies localization of the delivery vehicle in the vicinity of an organ or tissue site, 
while targeting is based on delivery to specific cell or tissue types. 
c) Sustained drug delivery (Zero order release profile): Ideally, the blood level of a drug 
would remain constant throughout the delivery period, yielding a continuous release 
profile consistent with zero-order kinetics35. However, injected or ingested drugs 
follow first-order kinetics, with high blood levels after initial administration (which 
could result in toxicity) followed by a rapid decrease in blood concentration (resulting 
in low drug efficacy). This drug release profile is undesirable; advantages of a 
continuous release include reduced risk of toxic effects, predictable and extended 
duration of drug action, and reduced frequency of dosing. See Fig. II.5. 
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d) Modulated drug delivery (nonzero-order release profile): Patterning release profile 
still remains a great challenge in drug delivery. A delivery system with a manipulable 
nonzero-order profile would ideally be tunable to each situation. 
e) Feedback controlled drug delivery: The ideal drug delivery system is the feedback 
controlled system, consisting of drug release in response to a therapeutic marker. Two 
classes can be defined: modulated devices, in which monitoring the chemical 
environment is possible in order to change the delivery rate continuously, and 
triggered devices, in which no release takes place until it is triggered by a marker or an 
external stimuli. 
f) Implantable controlled drug delivery devices: implantable devices are very attractive 
for a number of classes of drugs, particularly those that cannot be delivered via the 
oral route or are irregularly absorbed via the gastrointestinal tract. For certain diseases 
that require chronic administration of drugs, an implantable release device is highly 
useful. The monoliths developed in this project have a potential use as implantable 
controlled drug delivery devices applied in traumatology and orthopedic surgery. In 
these scenarios, bacterial infection after implantation is very common, making 
antibiotic-delivering implants an attractive option. Moreover, in cases where bone 
regeneration is necessary, the controlled release of growth factors may enhance the 
healing process after a fracture. 
 
 Fig. II.5. Zero-order (b) and first-order (a) kinetic profiles. A zero-order profile is preferable, as only one dose is 
necessary to maintain constant drug concentration within the therapeutic range for a prolonged period of time. 
Important parameters to consider in the design of a drug delivery vehicle include36: 
a) use of biocompatible materials with simple robust processes for biomaterial assembly, 
conjugation chemistry, and purification steps; 
b) ability to optimize in parallel the numerous biophysicochemical parameters of 
targeted drug delivery vehicles important for pharmacokinetic control and possible cell 
uptake; and 
c) development of scalable unit operations amenable to manufacturing large quantities 
of targeted drug delivery systems needed for clinical translation. 
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One of the applications of the present investigation is based on the study of the release of a 
model antibiotic (namely cefuroxime sodium salt) from mesoporous powder and bimodal 
monolithic SBA-15, in order to assess differences between morphologies and pure-silica 
functionalized surfaces. Cefuroxime is a type of antibiotic called a cephalosporin, related to 
penicillin. First-generation cephalosporins are active predominantly against Gram-
positive bacteria, and successive generations have increased activity against Gram-
negative bacteria. 
The impact of mesoporous silica as a drug delivery vehicle is described below. 
Mesoporous silica in drug delivery 
Mesoporous silica matrices have been investigated as potential drug carriers due to the 
following features37: 
a) Ordered pore network: as was previously described, mesoporous silica has a 
characteristic highly ordered array of pores whose structure depends on synthesis 
conditions. The ordered mesopore network is therefore tunable very homogeneous in 
size, allowing fine control of drug loading and release kinetics; 
b) High pore volume: large drug loads are viable; 
c) High surface area: implies high potential for drug adsorption; 
d) Silanol-covered surface: possible functionalization to allow better control over drug 
loading and release; 
e) Biocompatibility38. 
Various studies of release of model drug molecules from mesoporous silica matrices of 
different pore sizes have been carried out, suggesting that several factors could affect the 
release profile of the hosted molecule. Studies on release of model drug molecules of different 
molecular sizes from mesoporous silicas with a cubic pore ordering39 indicated that release 
tends to become slower as the pore size of the matrix decreases or the molecular size of the 
drug increases, and release rate was decreased further by functionalizing the mesopore wall 
(see following section). Comparison studies of release of a model antibiotic from hexagonally-
ordered mesoporous silica powder and discs40, resulting in release with a higher degree of 
control than conventional presentations of the antibiotic. It was also observed that release was 
slower and more controlled from disks than from powders. 
Organic-modified mesoporous silica 
The interaction between mesoporous matrices and drugs is also decisive for designing 
controlled drug delivery systems for clinical applications; the drug-material interaction is 
determinant regarding the adsorption and delivery behavior of the drug. One of the 
characteristics of mesoporous silica materials is the presence of a high concentration of silanol 
groups in the mesopores, which can be functionalized for the control of pore size and surface 
properties. Reactive and passive organic groups can be incorporated into the solid either by 
simultaneous condensation of corresponding silica and organosilica precursors (co-
condensation), by incorporating organic groups as bridging components directly and 
specifically into the pore walls by the use of bis-silylated single-source organosilica precursors 
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(production of periodic mesoporous organosilicas) or by subsequent modification of the pore 
surface of a purely inorganic silica material (grafting)22.  
In the present study, SBA-15 was modified by grafting, which refers to the subsequent 
modification of the inner surfaces of mesostructured silica phases with organic groups. This 
process is carried out primarily by reaction of organosilanes of the type (R’O)3SiR; in principle, 
it’s possible to functionalize with a variety of organic groups by modifying the organic residue 
(see Fig. II.6). 
 
Fig. II.6. Grafting for organic modification of mesoporous silica with terminal organosilanes
22
. 
It must be taken into account that functionalization involves a decrease in pore size, which can 
directly affect the release kinetics, especially for drugs with a size similar to that of the pore 
diameter41. 
Several investigations of drug release from functionalized mesoporous silica have been 
reported. Functionalization of SBA-15 with long alkyl chains resulted in a decreased release 
rate compared to as-calcined SBA-1541. Postsynthesis amine-functionalized SBA-15 yielded 
more control of release kinetics than the as-calcined samples: ibuprofen release rates were 
improved due to presence of ionic interaction between carboxyl groups in ibuprofen and 
amine groups on the surface of SBA-15, and release of bovine serum albumin (BSA) was 
improved due to o the balance of electrostatic interaction and hydrophilic interaction between 
BSA and the SBA-15 matrix10. 
Drug release profiles and kinetics 
The drug delivery profile is very relevant in the design of a drug delivery system. Release 
kinetics can be optimized by understanding the release process and determining the release 
mechanism. For many DDS, the drug release process can be modeled by a dissolution profile. 
For mesoporous silica, it has been shown that drug release is diffusion controlled40,42, making it 
possible to calculate kinetic parameters for comparison purposes. 
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Fig. II.7. Common release profiles for mesoporous materials
37
. 
Fig. II.7 shows common release profiles for mesoporous materials37. Profile a corresponds to 
unmodified surfaces, in which an initial burst release is followed by a slow release; this profile 
is desirable when an immediate high dose is required, as in acute infections. Profile b is 
associated with diffusion or dissolution processes, and generally follows first-order kinetics 
with respect to drug concentration. Profile c corresponds to zero-order kinetics, in which the 
release process is constant and dependent on time; this kind of profile is desirable for long-
term drug delivery systems. Profile d represents a stimulus-responsive system in which 
external changes (such as pH, temperature, magnetic field, etc.) allow controlled release. 
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III. Experimental Methods 
III.1. MESOPOROUS SILICA SYNTHESIS AND FUNCTIONALIZATION 
All of the work carried out was based on the hexagonally-ordered fibrous SBA-1517. 
III.1.1. SBA-15 powder synthesis 
Materials 
Fibrous SBA-15 was synthesized using Pluronics (P123, PEO20PPO70PEO20, Sigma-Aldrich, Fig. 
II.3) as a structure directing agent , tetraethyl orthosilicate (TEOS, 98%, Sigma-Aldrich, Fig. II.4) 
as a silica precursor, hydrochloric acid (HCl, 37%, Sigma-Aldrich) to control acidity, ethanol 
(98%, Sigma-Aldrich) for washing and distilled water (DIW) as a solvent. 
Synthesis was carried out in a 250 ml beaker covered with laboratory film, stirring and heating 
was carried out on a hotplate magnetic stirrer (IKA® RCT basic). Aging was carried out in 
pressure reactors consisting of a stainless steel jacket and an internal removable teflon vessel 
(43 cm3, 4 vessels per synthesis) in a forced convection oven (Memmert). Filtration was carried 
out in a 1000 ml Büchner flask. Calcination was done in a ceramic crucible in a muffle furnace 
(Hobersal).  
Procedure 
In a typical synthesis, 4 g of P123 are dissolved at 37ºC in 120,8 ml DIW and 3,2 ml HCl, stirring 
at 350 rpm. After complete dissolution, 9,2 ml of TEOS are added drop by drop and the beaker 
is covered with laboratory film and left under stirring and heating for 24 h, and then aged for 3 
days in Teflon vessels at 100ºC. 
The solid product was then filtered and washed three times with DIW and dried for 24 h at 
room temperature. Removal of the organic template was achieved by calcination in ambient 
air from room temperature to 550ºC with a heating rate of 1ºC/min and holding time of 6 h at 
550ºC, and left to cool. 
III.1.2. SBA-15 powder functionalization 
As was previously mentioned (see section II.3), organic modification of the surface of SBA-15 
enables higher control of release. The experimental protocol for functionalizing SBA-15 is 
described below: 
Materials 
SBA-15 was functionalized with (3-Aminopropyl)triethoxysilane (APTES, Sigma-Aldrich, Fig. 
III.1), in anhydrous toluene (Sigma-Aldrich). 
 
Fig. III.1. Molecular structure of (3-Aminopropyl)triethoxysilane 
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Functionalization was carried out in a 250 ml three-neck round-bottom flask/reflux column 
setup, while stirring and heating on a hotplate magnetic stirrer (IKA® RCT basic). Filtration was 
carried out in a 1000 ml Büchner flask. 
Procedure 
Functionalization of SBA-15 powders was realized as follows: 1 g of SBA-15 was weighed in the 
flask which was coupled to the reflux column. Functionalization must be carried out in a 
humidity-free environment, so an inert gas line (typically Ar) was also coupled to the setup and 
the system is purged of humidity using a low gas flow during 30 minutes (the gas flow is 
adjusted so that powder remains motionless). The remaining neck was covered using a rubber 
plug. See Fig. III.2. 
 
Fig. III.2. Functionalization setup. 
After creating an inert atmosphere inside the flask, the gas line was removed and the neck 
immediately covered using a rubber plug. Functionalization must be carried out in organic 
media, so 20 ml of anhydrous toluene were added using a syringe while stirring at 300 rpm and 
heating to 120ºC. Upon reflux, 0,476 ml of APTES were added and the reaction was left 
between 7 and 8 h. 
The flask was then cooled and the solid is filtered and washed three times with ethanol. 
Powder was dried overnight in an oven at 45ºC. 
III.2. MONOLITH PREPARATION AND FUNCTIONALIZATION 
Mesoporous silica monoliths with a bimodal pore structure (mesopores and macropores) were 
prepared using gel-casting procedures, in which SBA-15 particles are entrapped in a cross-
linked polyacrylamide macromolecular network; the polymer/particle composition replicates 
the shape of the model used and the shape remains after polymer network removal.  
III.2.1. Monolith preparation 
Materials 
The elastic hydrogel/particle network was formed using the monomer acrylamide (Ac, 99%, 
Sigma-Aldrich, Fig. III.3), cross linker N-N’-methylene-bisacrylamide (BisAc, 99%, Sigma-Aldrich, 
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Fig. III.4) and initiatior ammonium persulfate (NH4)2S2O8 as a suspension in DIW. Monoliths are 
prepared with SBA-15 functionalized with APTES. This functionalization is lost after calcination 
(see section IV.1, TGA results. Monoliths exhibit higher mechanic stability when prepared with 
functionalized SBA-15 (see section IV.1, mechanical stability results).  
 
Fig. III.3. Molecular structure of monomer acrylamide. 
 
 
Fig. III.4. Molecular structure of cross-linker N-N’-methylene-bisacrylamide. 
Monoliths were prepared in 3 mm i.d. glass tubes placed inside PMMA loaded microcentrifuge 
tubes that function as a support (see Fig. III.5). Suspension underwent centrifugation in a 
microcentrifuge (Labnet Spectrafuge 24D) with a maximum capacity of 24 x 1,5/2 ml.  Hydrogel 
hardening and drying were carried out in a forced convection oven (Memmert) and calcination 
in a ceramic crucible in a furnace. 
  
Fig. III.5. Monolith preparation sequence (left); microcentrifuge and glass tubes (left). 
Procedure 
The weight ratio of monomer, cross-linker and initiator in DIW was 5:0,5:0,05:100, with a 
weight content of SBA-15 of 2%. Reagents were mixed in a vial and sonicated for 10 minutes to 
ensure a homogeneous suspension. The suspension was transferred into glass tubes and 
centrifuged at 3500 rpm for 5 min. Silica particles were packed at the bottom of the tube by 
centrifugal force and the supernatant was replaced with fresh suspension and centrifuged 
once again, repeating until the desired height was achieved. 
Tubes were capped and cured in an oven at 50ºC for 1 h (monomer and cross-linker 
polymerization, hydrogel formation) and then uncapped and left at this temperature overnight 
for hydrogel hardening. 
The hard column was dried thoroughly in a vacuum oven at 60ºC and 100 mbar for 48 h, and 
the glass tubes were removed from inside microcentrifuge tubes and calcined in a ceramic 
crucible in ambient air from room temperature to 700ºC with a heating rate of 2ºC/min and 
holding time of 10 h at 700ºC. 
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After calcination, hard silica monoliths can be easily removed from glass tube models and 
stored for later use. 
Mechanical stability was tested by submerging in PBS for a prolonged period of time. Initial 
monoliths were lyophilized, weighed and left in PBS for 21 days at 37ºC, then filtered and 
lyophilized again, to determine mass loss. 
III.2.2. Monolith functionalization 
Functionalization of monoliths is analogous to powder functionalization, except the monoliths 
did not undergo stirring but agitation is achieved due to the boiling of toluene (stirring with a 
magnetic stirrer would crack monoliths). Filtration in this case was carried out on filtration 
paper. 
III.3. MESOPOROUS MATERIAL AND MONOLITH CHARACTERIZATION 
Various techniques were applied to characterize the SBA-15 powder and monoliths. Below is a 
detailed account of each one, along with the conditions used for each case. 
III.3.1. Scanning electron microscopy 
With scanning electron microscopy (SEM) it’s possible to obtain high-resolution images of a 
sample by scanning the surface with a high-energy electron beam (KeV) in a raster pattern.  
The topographical image is constructed by analysis of the signal of secondary electrons 
emitted by the sample’s surface upon the action of the high-energy electron beam. 
 Samples need previous preparation to ensure electrical conductivity; this is achieved by 
covering the sample with a thin layer of a conducting material (in our case gold was employed) 
via vacuum sputter coating.  
SEM was used to determine the morphology of SBA-15 powder and confirm its fibrous 
structure, as well as to calculate particle size and distribution. It was also possible to view the 
structure and morphology of the monolithic silica (particle packing).  SEM imaging was carried 
out on a FEI™ Inspect F50 Scanning Electron Microscope and on a FEI™ Quanta™ Scanning 
Electron Microscope. 
III.3.2. Transmission electron microscopy 
By transmitting a beam of electrons through an ultrathin specimen (<200nm), it’s possible to 
obtain a very high-resolution image due to the electron-sample interaction. Part of the 
incident beam is transmitted, another part is dispersed and a fraction of the beam interacts 
with the sample giving way to a series of different interactions that are useful for obtaining 
information on the sample, such as morphology and crystalline structure.  
Transmission electron microscopy (TEM) sample preparation involves dissolving solid silica 
samples in non-polar media (ethanol) and sonicating to ensure a better dispersion. A drop of 
this suspension is deposited on a mesh grid and left to dry, while the particles remain. 
TEM was used to study SBA-15 powder pore size and distribution. TEM imaging was carried 
out on a FEI™ Tecnai F30 Microscope. 
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III.3.3. Small-angle X-Ray diffraction 
Small-angle X-ray diffraction (SA-XRD) consists of analyzing diffraction of X-rays to obtain 
information on the crystallographic phases of a sample. The wavelength of X-rays is of the 
same order of magnitude as interatomic distances within crystalline materials, thus it is 
possible for X-rays to be diffracted and crystal diffraction patterns can be obtained.  
SA-XRD patterns obtained were employed to confirm the characteristic hexagonal structure of 
SBA-15, for powder and monoliths alike. CuKα radiation (λ = 1,5406 Å, 40kV) in the range of 0,6 
to 10,0º (2Ɵ) was used (Philips™ X’Pert Plus, Faculty of Pharmacy, Universidad Complutense de 
Madrid). 
III.3.4. Nitrogen adsorption 
Adsorption occurs when a gas or liquid solute (adsorbate) accumulates on the surface of a 
solid (adsorbent). In the case of a gas adsorbate, gas molecules accumulate on the solid 
surface to form an initial monolayer and repeated multilayers as the partial pressure of the gas 
increases. Techniques based on physical adsorption allow us to determine properties of micro 
and mesoporous materials such as pore shape and size, specific surface area and specific pore 
volume.  
By means of nitrogen adsorption evaluations, it was possible to determine properties of SBA-
15 powder and monoliths based on the Brunauer-Emmett-Teller (BET) and Barret-Joyner-
Halenda (BJH) theories, namely specific surface area, specific pore volume and pore size 
distributions, as well as pore structure via analysis of adsorption isotherms.  Measurements 
were carried out (after previous degasification in vacuum at 473 K for 3 h) at 77K for 8 hours 
for unfunctionalized materials and 3 hours for functionalized materials, on a surface area and 
pore size analyzer (Micromeritics™ Tristar 3000). 
III.3.5. Mercury  porosimetry  
Porosimetry is useful when determining macropore properties. A non-wetting liquid, 
specifically mercury, is forced to intrude the pore structure of as-synthesized monoliths that 
have been previously degassed. Roughly, the volume of mercury that intrudes into the samples 
due to an increase of pressure is equivalent to the pore volume in an associated size range 
depending on the pressure employed.  
Mercury porosimetry was used to determine total and interstitial porosity and interstitial pore 
size of SBA-15 monoliths. Analysis was carried out on a mercury intrusion porosimeter 
(Micromeritics™ AutoPore IV). 
III.3.6. Thermogravimetric analysis 
Thermogravimetric analysis (TGA) enables us to determine the composition of a sample by 
continuously increasing the sample temperature in a controlled environment and recording 
the mass loss, which is associated to the decomposition of the phases within the sample. 
Materials constituting the sample decompose at different temperatures, making a qualitative 
and quantitative analysis possible by differentiation of the thermogram obtained (weight vs. 
temperature). 
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TGA was employed to confirm the presence of APTES and cefuroxime in the sample. 
Measurements were carried out using a heating rate of 5ºC/min until 900ºC using a N2 flow of 
15ml/min (TA Instruments™ Thermogravimetric Analyzer). 
III.3.7. UV-Visible spectroscopy  
UV-Visible spectroscopy (UV-Vis) is a colorimetric technique widely used to identify organic 
and inorganic species within a sample.  
UV-Vis was used for two purposes: as a tool to determine the amount of cefuroxime loaded 
onto SBA-15 powders and monoliths and to study the release mechanisms of said materials. 
UV-Vis measurements were carried out on an UV-Vis spectrophotometer (8453 UV-Visible, 
Agilent™) at 278 nm, which is the characteristic absorbance wavelength of cefuroxime. The 
equipment consists of a light source of two lamps (wavelength range from 190 to 1100 nm), a 
monochromator to separate different wavelengths and a detector.  
III.4. CEFUROXIME LOADING AND RELEASE 
Drug delivery experiments were conducted on four different samples, namely unfunctionalized 
and functionalized SBA-15 powders (P-SBA-15 and P-SBA-15’) and monoliths (M-SBA-15 and 
M-SBA-15’, respectively). 
III.4.1. Cefuroxime loading 
Loading of cefuroxime sodium salt (CEF, Sigma-Aldrich, Fig. III.6) onto SBA-15 powders and 
monoliths was accomplished using the same technique for both materials, in order to establish 
differences regarding the amount of drug adsorbed onto the mesoporous material, specifically 
due to the difference in macroscopic configuration. 
 
Fig. III.6. Molecular structure of Cefuroxime Sodium Salt (CEF). 
Prior to loading, it is necessary to dehydrate the pores of the material, which is done by 
lyophilization (Telstar Cryodos Lyophilizer). 
Previous work carried out by members of the NFP group have demonstrated that loading of 
cefuroxime  in a 1:2 proportion with respect to the mesoporous material yields the highest 
possible loads; for this reason this proportion was chosen as a base for cefuroxime loading 
(Carmona and Balas, unpublished data).  The corresponding volume of a solution of 
cefuroxime in DIW with a concentration of 5 mg/ml was added onto approximately 20 mg of 
SBA-15 powders and monoliths alike immediately after lyophilizing in a glass vial. For monolith 
loading, the vial underwent moderate stirring (to avoid monolith damage) in an orbital shaker 
(IKA®KS 130 Control) at 230 rpm and room temperature; for powder loading the vial was 
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placed on a roller and tilt mixer (SELECTA Movil-Rod). After 24 hours, the powders and 
monoliths were filtered on laboratory filter paper and washed once with 1ml DIW, and left to 
dry in ambient conditions for another 24 hours. 
III.4.2. Cefuroxime release 
Cefuroxime release mechanisms from SBA-15 powders and monoliths were determined using 
UV-Vis spectroscopy in a continuous mode (see Fig. III.7). It was possible to measure the 
absorbance of the release media in order to monitor cefuroxime release. Measurements were 
carried out at controlled time intervals at the characteristic absorbance wavelength of 
cefuroxime. Absorbance measurements were carried out in the UV-Vis spectrophotometer 
described in section III.3.7. 
 
Fig. III.7. Continuous-measurement release setup.  
The setup consists of a circuit comprising polyurethane piping and a peristaltic pump that 
directs the release media from the initial release vial through a quartz cuvette where 
absorbance measurements are executed and back to its original vial. The release vial was 
placed inside an oil bath on a heating plate (IKA® RCT basic). Release media must be filtered 
prior to entering the cuvette as solid particles would result in light scattering and, therefore, 
erratic measurements. For this a stainless steel filter was placed on the pipe entrance. 
Release experiments were conducted as follows: approximately 20 mg of cefuroxime-loaded 
SBA-15 powder or a cefuroxime-loaded monolith were placed in the glass vial. The filter and 
pipe exit were both placed inside the vial and set in place with laboratory film which also seals 
the vial to prevent evaporation of release media. After the setup is complete, 5 ml of release 
media were added using a syringe. A 1X phosphate buffered saline solution (PBS) was used as 
a release media, at 37ºC in order to simulate physiological conditions as closely as possible. 
Agitation was achieved due to the flow of release media, as using magnetic stirrers would 
crack monoliths. 
Time-based measurement specifications are as follows: the first measurement was conducted 
15 s after the program was initialized (program should be initialized immediately after PBS is 
added to loaded mesoporous material), then every 60 s until 1000 s. After this, measurements 
were carried out with an increment of 10% in time with respect to the previous measurement 
given that release tends to be slower after the initial burst. Measurements are recorded for a 
maximum of 1,8·105 s (approximately 2 d). 
UV-Vis 
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IV. Results and Discussion 
IV.1. MONOLITH AND MESOPOROUS MATERIALS CHARACTERIZATION 
Powder and monolithic SBA-15 were characterized using the techniques detailed in section 
III.3. The results obtained are explained in this section.  
IV.1.1. SEM Imaging 
The fibrous morphology of P-SBA-15 and M-SBA-15 can be clearly seen in SEM micrographs 
(Fig. IV.1). An image analysis to determine particle dimensions resulted in diameters between 
4,5 and 7,5µm and lengths between 75 and 105µm, with a highly irregular distribution. The 
final micrograph shows how SBA-15 particles agglomerate to form the solid monolithic 
structure (see Fig. IV.2 for photographs of the final products). 
 
  
Fig. IV.1. SEM micrographs of synthesized fibrous SBA-15. The final micrograph is an image of a longitudinal 
section of a monolith. 
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Fig. IV.2. Calcined monoliths. 
IV.1.2. TEM Imaging 
TEM micrographs (Fig. IV.3) of P-SBA-15 show well-defined pores and a uniform pore size 
distribution. An image analysis to determine pore size resulted in an average of 5,60±0,12 nm. 
The characteristic hexagonal pore structure of SBA-15 can be clearly seen on the inset 
micrograph. 
 
  
Fig. IV.3. TEM micrographs of SBA-15 powders. 
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IV.1.3. SA-XRD Analysis 
SA-XRD spectra for P-SBA-15 (Fig. IV.4) show three clear peaks which can be indexed as (1 0), 
(1 1) and (2 0) reflections. These are characteristic of the reflections of a 2D hexagonal 
symmetry (p6mm).  
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Fig. IV.4. Small-angle X-Ray Diffraction spectrum for P-SBA-15. Three characteristics peaks of a hexagonally-
ordered structure are shown. 
 
IV.1.4. Nitrogen adsorption analysis 
Materials pore shape and size, specific surface area and specific pore volume were determined 
by nitrogen adsorption evaluations. Adsorption isotherms are functions that relate the 
amount of adsorbate adsorbed at equilibrium, to the pressure of the adsorbate in the gas 
phase, at a constant temperature. Adsorption of a gas depends, amongst other things, on the 
porous structure of the adsorbant. Therefore it is possible to determine additional information 
on pore shape by adsorption isotherm analysis. 
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Fig. IV.5. Adsorption/desorption isotherms. 
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According to the IUPAC, there are six types of physical adsorption isotherms, and four types of 
hysteresis43.  In Fig. IV.5, the adsorption isotherms of P-SBA-15 and the monolithic forms are 
shown. The isotherms can be classified as type V, which are associated to mesoporous 
structures. Hysteresis in corresponds to the type H-1, which is characteristic of well-defined 
cylindrical pores and uniform pore size distribution. This information confirms the information 
collected from TEM micrographs in which an ordered and uniform mesoporous structure was 
observed. 
Using the BET theory model, the specific surface areas of each material were determined. Pore 
sizes and specific pore volume were calculated using the BJH theory. The table below 
summarizes these properties. 
Table IV.1. SBA-15 powder and monolith properties determined by N2 adsorption. 
 P-SBA-15 M-SBA-15 M-SBA-15’ 
Pore shape Cylindrical Cylindrical Cylindrical 
Pore size (nm) 6,9 6,8 6,7 
Specific surface area (m
2
/g) 914,6 547,0 294,4 
Specific pore volume (cm
3
/g) 1,16 0,90 0,50 
P-SBA-15: Powder SBA-15, M-SBA-15: Monolithic SBA-15; M-SBA-15’: APTES modified monolithic SBA-15 
 
There is a reduction in specific surface area and pore volume after functionalization, due to the 
incorporation of organic moieties. It has been suggested that this reduction can be attributed 
to the blockage of much smaller pores (>2nm) that may be present with a broad distribution 
within the mesoporous materials44. The grafting of organic moieties modifies the silica surface, 
making it difficult for nitrogen molecules form the monolayer necessary for N2 adsorption 
measurements on the material surface. Upon applying the aforementioned mathematical 
models to determine specific surface area and pore volume, a reduction is obtained due to the 
direct dependency of the models to the amount of N2 adsorbed. As was detailed in sections 
III.1 and III.2, materials were functionalized with (3-Aminopropyl)thriethoxysilane (APTES). The 
approximate size of this molecule is 1,3nm in length and 0,7 nm in diamterer45. 
The reduction in specific surface area and pore volume between the powder and monolithic 
form of SBA-15 can be attributed to the incorporation of an additional Si layer on the surface 
of the material, aside from the pore blockage previously mentioned. As was explained in 
section III.2, monoliths are prepared with previously functionalized SBA-15 powders due to the 
fact that they showed a higher mechanical stability than those prepared with unfunctionalized 
SBA-15 (see section IV.1.6). Upon calcination during monolith preparation, the organic tails of 
APTES are lost, but the additional Si atom remains within the structure. Further 
functionalization (M-SBA-15’) would result in an even lower specific surface area and pore 
volume. 
The change in mesopore size however is hardly significant, suggesting that grafting of small 
organic moieties on larger pores does not affect their size, but again confirming that blockage 
of micropores with the same moieties is possible. 
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IV.1.5. Mercury porosimetry analysis 
Further characterization of the porous structure of SBA-15 monoliths was carried out by 
mercury intrusion porosimetry evaluations. Due to the shape of SBA-15 particles, monoliths 
have a bimodal array of pores: the characteristic mesopores of SBA-15 and macropores in the 
range of microns that correspond to the interstitial sites formed within the monolith (see 
section IV.1.1). Fig. IV.6 shows the intrusion and extrusion curves of M-SBA-15 and M-SBA-15’. 
Pore sizes and interstitial and total porosity of monoliths are presented in the table below. 
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Fig. IV.6. Hg porosimetry of unmodified (SBA-15) and modified (SBA-15+APTES) monoliths. 
Interstitial pores are larger than the mesopores and therefore hold more mercury than particle 
pores. Moreover, unfunctionalized monoliths will hold more mercury than their functionalized 
counterparts; total intrusion volume for M-SBA-15 was 4,756 ml/g, while for M-SBA-15’ 
intrusion reached 2,348 ml/g. 
Two pore sizes are discernible in Fig. IV.6 (intrusion curve), corresponding to the pore 
distribution described above. 
Table IV.2. SBA-15 monolith properties determined by Hg porosimetry. 
 M-SBA-15 M-SBA-15’  
Interstitial pore size (µm) 3,43 3,19 
Interstitial porosity (%) 47,6 47,6 
Total porosity (%) 84,5 83,4 
 
Interstitial pores of M-SBA-15 are slightly larger than those of M-SBA-15’, and total porosity is 
reduced after functionalization, most likely due to micropore blockage as was described in the 
previous section. The slight decrease in total porosity is also due to pore blockage. 
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IV.1.6. Thermogravimetric Analysis 
Organic modification of SBA-15 powders and monoliths was confirmed via TGA. The figure 
below show TGA and derivative TGA curves of modified and unmodified SBA-15 powders and 
monoliths. A peak is clearly discernible in the derivative curve for the temperature range of 
400 to 600ºC46, which is attributed to the decomposition of APTES in a nitrogen atmosphere. 
This indicates effective surface modification. 
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Fig. IV.7. TGA spectra for APTEs-modified SBA-15 powders. 
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Fig. IV.8. TGA spectra for APTES-modified SBA- monoliths.  
Monoliths showed a 3,2% in weight of effective surface modification versus 5,9% for powders. 
Monoliths yield a lower silanization given that they are prepared using previously 
functionalized SBA-15 powders. Although the organic groups of APTES are lost after monolith 
calcination, a decrease in the hydroxyl sites available for functionalization with respect to the 
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powder counterpart is possible, resulting in a less effective organic modification. Moreover, 
diffusion of the functionalization agents to the interior of monoliths is difficult given their 
macroscopic morphology. 
IV.1.7. Mechanical stability assays 
Mechanical stability of monoliths was determined by calculating the difference in mass for 
monoliths left for 21 days in PBS at 37ºC. Mass loss for SBA-15 monoliths prepared with 
unfunctionalized material was of 37,4%, while for those prepared with functionalized SBA-15 
mass loss was 4,2%. Monoliths prepared with functionalized SBA-15 proved to be more 
resistant to dissolution in aqueous media, for this reason they were chosen as matrices for 
drug delivery experiments. 
IV.2. CEFUROXIME RELEASE 
IV.2.1. Cefuroxime loading 
Materials under study (P-SBA-15, P-SBA-15’, M-SBA-15 and M-SBA-15’) were soaked during 
24h in a solution of the model antibiotic (cefuroxime sodium salt, CEF) to entrap drug 
molecules within the available pores (see section III.4). 
Effective uptake of CEF was confirmed by TGA (see Fig. IV.9-Fig. IV.11). A peak is observed in 
the derivative curve from 100 to 110ºC which corresponds to elimination of water from 
samples. From 200 to 300ºC, a peak is discernible which can be attributed to decomposition of 
cefuroxime. As was previously mentioned, the peak in the range from 400 to 600ºC 
corresponds to the decomposition of APTES in the sample. 
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Fig. IV.9. TGA spectra for cefuroxime sodium salt. 
IV. RESULTS AND DISCUSSION 
 
30 
  
0 200 400 600 800 1000
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
W
e
ig
ht
 
(%
)
Temperature (؛C)
 P-SBA-15+CEF
 P-SBA-15'+CEF
0,00
0,05
0,10
 
 
D
e
riv
.
 
W
e
ig
ht
 
(%
/؛C
) P-SBA-15+CEF deriv.
 P-SBA-15'+CEF deriv.
 
Fig. IV.10. TGA spectra for cefuroxime-loaded powders. 
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Fig. IV.11. TGA spectra for cefuroxime-loaded monoliths. 
According to TGA, CEF was effectively loaded onto SBA-15 powders and monoliths in the 
following ascending order, represented as a weight percentage of CEF in SBA-15: M-SBA-15 
(1,07%), M-SBA-15’ (1,20%), P-SBA-15 (1,24%) and P-SBA-15’ (2,27%).  
Loading of CEF was calculated by a mass balance between initial antibiotic solution and 
supernatant after 24h of loading; were determined by UV-Vis spectroscopy. Drug content of 
the different matrices studied are shown in the table below. 
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Table IV.3. Cefuroxime uptake on SBA-15 powders and monoliths. 
Material % wt with respect 
to Q0 
% wt with respect 
to SBA-15 wt 
P-SBA-15 17,59 8,80 
P-SBA-15’ 18,64 9,31 
M-SBA-15 14,80 7,40 
M-SBA-15’ 16,93 8,46 
Q0: mass of cefuroxime in initial loading solution 
 
TGA and UV-Vis calculations indicate that the material with the highest CEF uptake is P-SBA-
15’. In contrast to the unfunctionalized P-SBA-15, a higher loading is possible due to amino 
groups readily available on the P-SBA-15’ surface which increase the drug-surface interaction. 
This increase is due to possible ionic interactions between protonated amino groups and the 
carboxyl group of CEF, versus the weaker hydrogen bonds that are formed between the 
carboxyl group and the hydroxyl group available on unfunctionalized surfaces10.  
Uptake of CEF on monoliths is lower than that of the powder counterparts. Powders exhibit a 
higher surface area to volume ratio and are therefore in higher contact with the initial loading 
solution; diffusion of said solution through the monolith may prove difficult. 
IV.2.2. Cefuroxime release 
Release kinetics are studied as a function of time, and for the case of a water-soluble drug 
incorporated in a matrix, it is assumed that release is due to diffusion35. Generally, for 
mesoporous materials, release profiles tend to exhibit and initial burst release followed by a 
more controlled release pattern37.  In the present study, variations in this abrupt release are 
due to the macroscopic morphology of the release matrix (powder and monolithic materials). 
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Fig. IV.12. Cumulative release profiles of CEF from materials under study. 
According to Fig. IV.12, release of CEF from both unfunctionalized and functionalized 
monoliths exhibits an initial burst release followed by a more controlled delivery. This behavior 
is the result of CEF diffusing from the macropores of monoliths. A large amount of the total 
CEF loaded may be entrapped within the macropores, creating a drug reservoir. Due to the 
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larger size of these pores, diffusion to the release media is easier and a large amount of 
material is delivered abruptly. A more controlled release can be observed for M-SBA-15’ in 
contrast to M-SBA-15 after the initial burst. This is the result of functionalization of mesopores, 
which makes drug diffusion towards the release media more difficult due to the ionic 
interactions between said molecules and amino groups on the mesopore surface. 
Fig. IV.12 also confirms that cefuroxime release from powders is slower than from monolithic 
counterparts. As there are no large drug reservoirs, initial burst release is small and can be 
attributed to desorption of drug molecules located on mesopore entrances. A more controlled 
release from P-SBA-15’ as compared to P-SBA-15 is expected for the same reason described 
above; functionalization will result in retention of drug molecules yielding slower delivery. 
Cumulative profiles can be used to accomplish dissolution studies for in-vitro release. Release 
kinetics parameters were calculated in order to establish a comparison between release 
profiles, based on the cumulative adsorption plot. The diffusion model chosen to study the 
delivery of CEF from each system assumes extraction of the drug from the pores of the matrix 
by means of contact with the release media; the drug dissolves slowly into the fluid phase and 
diffuses from the system along the pores. Higuchi developed a theoretical model that can be 
applied to these studies. The equation that is used to predict the release rate is: 
 = 


  …(Ec. IV.1) 
where Q is the amount of drug released after time t and k is the release constant. The amount 
of drug released was plotted against the square root of time and the data was fitted to a linear 
regression. The threshold limit for the valid application of the Higuchi model was adjusted to 
the time when said fitting had the highest possible regression coefficient. This adjustment 
offers information on the kinetic of release as well as the time for which delivery follows this 
particular model. 
Table IV.4. Kinetic constants for the systems under study. 
Material k r
2
 Time limit (h) 
P-SBA-15 16,203 0,95 17,9 
P-SBA-15’ 10,265 0,95 46,25 
M-SBA-15 63,637 0,96 1,61 
M-SBA-15’ 40,988 0,96 2,52 
k: kinetic constant, r2: regression coefficient  
As is expected, the matrix with the highest kinetic constant is M-SBA-15, followed by M-SBA-
15’, P-SBA-15 and with P-SBA-15’ exhibiting the slowest release. This again indicates that the 
monolithic form yields a faster delivery, and functionalization enables more control over 
kinetics. This trend can also be observed in the time limits for modeled release, being P-SBA-
15’ the matrix that follows the Higuchi model for the longest period of time. After the time 
limit, it is assumed that quasi-equilibrium has been reached and delivery is very slow. 
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Fig. IV.13. Absolute release profiles. Release calculated with respect to effective CEF loaded (Ql). 
Fig. IV.13 shows effective release with respect to CEF loaded onto each material. The material 
with the highest amount of drug released is M-SBA-15, with 9,4% of release. This can be 
attributed to the fact that there are weak interactions between drug molecules and surface, as 
the material is unfunctionalized. Moreover, there are drug reservoirs within the macropores 
that represent a large part of the total amount of drug loaded; release from these reservoirs is 
thought to be faster as diffusion from said macropores is less difficult than diffusion from 
mesopores.  
M-SBA-15’ exhibits a release profile similar to that of its unfunctionalized counterpart; 
however less drug is delivered to the release media (7,6%).  As was previously mentioned, 
functionalization enables a more controlled delivery of the drug, therefore a slower release is 
expected. It is possible that release has not yet reached equilibrium after the set experimental 
release time, and more drug molecules can be delivered to the release media. However, it is 
commonly observed that the complete desorption of the drug is seldom found37, due to the 
equilibrium achieved at the end of the desorption process that results in partial retention of 
the drug within the delivery matrix. In the case of functionalized matrices this is more evident 
due to stronger drug-surface interactions. 
Powder matrices exhibit less CEF delivery than monolith matrices (1,9% for P-SBA-15’ and 3,3% 
for P-SBA-15). In spite of higher loadings in powder matrices, delivery is slower because there 
are no large (macroporous) reservoirs that release high quantities of drugs in a short period of 
time; drug release depends solely on desorption of drug located inside the mesopores of SBA-
15 and near the surfaces of the pore entrance. The matrix P-SBA-15’ exhibits a slower release 
due to retention of drug molecules as an effect of ionic interaction between the amino groups 
of APTES and the carboxyl groups of CEF; the portions of the curve after burst release are 
parallel in the case of P-SBA-15’ and M-SBA-15, indicating similar release kinetics for the 
functionalized matrices.
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V. Conclusions 
An effective synthesis of fibrous SBA-15 powder with an ordered hexagonal mesoporous 
structure was achieved, as well as functionalization of the resulting mesoporous silica with the 
aminosilane APTES. 
Successful functionalization of SBA-15 enabled preparation of mechanically stable monolithic 
SBA-15 that exhibited a bimodal pore structure, with macropores in the range of microns and 
the corresponding characteristic mesopores, confirmed by intrusion analysis, whereas without 
surface functionalization stable monolithic structures could not be prepared. Functionalization 
of said monoliths was also achieved however in a lower degree than the powder counterparts, 
due to difficult diffusion of the functionalizing agent to the interior of the monolith. 
Loading of a model antibiotic, namely cefuroxime sodium salt onto amino-functionalized and 
unfunctionalized SBA-15 powders and monoliths yielded higher loadings for powders, as well 
as higher loadings for functionalized matrices, given the strong ionic interaction that occurs 
between amino groups and carboxyl groups present in cefuroxime. 
Controlled drug delivery studies of cefuroxime from amino-functionalized and 
unfunctionalized SBA-15 powders and monoliths were conducted, resulting in a faster release 
from monolithic matrices than powder counterparts due to the bimodal porous structure in 
which macropores can function as initially fast-releasing drug reservoirs. Furthermore, a more 
controlled release was achieved via functionalization with aminosilanes. 
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